Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data

Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data

<p><strong>Background</strong></p> Typhoid conjugate vaccines are being introduced in low-income and middle-income countries to prevent typhoid illness in children. Vaccine effectiveness studies assess vaccine performance after introduction. The test-negative design is a comm...

Detaylı Bibliyografya
Asıl Yazarlar:	Liang, Y, Driscoll, AJ, Patel, PD, Datta, S, Voysey, M, French, N, Jamka, LP, Henrion, MYR, Ndeketa, L, Laurens, MB, Heyderman, RS, Gordon, MA, Neuzil, KM
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2022

Benzer Materyaller

Distinct climate influences on the risk of typhoid compared to invasive non-typhoid Salmonella disease in Blantyre, Malawi
Yazar:: Thindwa, D, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Accelerating typhoid conjugate vaccine introduction: what can be learned from prior new vaccine introduction initiatives?
Yazar:: Jamka, LP, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Early insights from clinical trials of typhoid conjugate vaccine
Yazar:: Neuzil, KM, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Typhoid conjugate vaccines: Advancing the research and public health agendas
Yazar:: Birkhold, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Distinct climate influences on the risk of typhoid compared to invasive non-typhoid Salmonella disease in Blantyre, Malawi
Yazar:: Deus Thindwa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

A trial of a typhoid conjugate vaccine in children in Malawi
Yazar:: Priya Venkatesan
Baskı/Yayın Bilgisi: (2021-12-01)

Introduction of typhoid conjugate vaccines in Africa and Asia
Yazar:: Neuzil, K, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Typhoid Fever and Invasive Nontyphoid Salmonellosis, Malawi and South Africa
Yazar:: Nicholas A. Feasey, ve diğerleri
Baskı/Yayın Bilgisi: (2010-09-01)

Prospects of future typhoid and paratyphoid vaccines in endemic countries
Yazar:: Shakya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
Yazar:: Nginache Nampota-Nkomba, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Typhoid conjugate vaccines: a step towards typhoid control
Yazar:: Shakya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The design and analysis of seroefficacy studies for typhoid conjugate vaccines
Yazar:: Liu, X, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school childrenResearch in context
Yazar:: Nginache Nampota-Nkomba, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
Yazar:: Shakya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study
Yazar:: Ashton, PM, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Ascertaining the burden of invasive Salmonella disease in hospitalised febrile children aged under four years in Blantyre, Malawi
Yazar:: Msefula, CL, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)
Yazar:: Voysey, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal
Yazar:: Shakya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Typhoid fever
Yazar:: Meiring, JE, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
Yazar:: Shakya, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis
Yazar:: Khanam, F, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia
Yazar:: Thindwa, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic typhoid alliance across Africa and Asia
Yazar:: Thindwa, D, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Cost-effectiveness of typhoid conjugate vaccine strategies in 54 gavi-eligible countries
Yazar:: Bilcke, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
Yazar:: Sodiomon B. Sirima, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Strategies for typhoid conjugate vaccines in endemic nations – authors' reply
Yazar:: Pitzer, VE, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in Malawi.
Yazar:: Nicholas A Feasey, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial
Yazar:: Qadri, F, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Typhoid conjugate vaccines: making vaccine history in Africa
Yazar:: James E. Meiring, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
Yazar:: Maile T. Phillips, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

The time is now to control typhoid
Yazar:: Pollard, A, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Yazar:: Sodiomon B. Sirima, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
Yazar:: Swarthout, TD, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

A Typhoid Epidemic in Rural Malawi: Real-world Challenges
Yazar:: C. Kachimanga, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data
Yazar:: Phillips, MT, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Opinion of Parents Regarding Conjugate Typhoid Vaccine
Yazar:: M.Hanif Memon, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Modeling the potential impact of typhoid conjugate vaccines
Yazar:: V.E. Pitzer, ve diğerleri
Baskı/Yayın Bilgisi: (2014-04-01)

Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
Yazar:: Theiss-Nyland, K, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
Yazar:: Mila Shakya, MPH, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

How can the typhoid fever surveillance in Africa and the severe typhoid fever in Africa programs contribute to the introduction of typhoid conjugate vaccines?
Yazar:: Jeon, HJ, ve diğerleri
Baskı/Yayın Bilgisi: (2019)